vs
Side-by-side financial comparison of SNDL Inc. (SNDL) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($213.7M vs $77.5M, roughly 2.8× SNDL Inc.).
SNDL Inc. is a Canada-based consumer goods company focused primarily on the cannabis sector, offering a range of recreational and medical cannabis products, alongside craft beer, wine and spirit offerings. It operates across cultivation, product development, distribution and retail segments, serving both wholesale and retail customers mainly in the North American market.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
SNDL vs USNA — Head-to-Head
Income Statement — Q1 2025 vs Q3 2026
| Metric | | |
|---|---|---|
| Revenue | $77.5M | $213.7M |
| Net Profit | — | $-6.5M |
| Gross Margin | 25.3% | 77.2% |
| Operating Margin | 6.7% | 0.6% |
| Net Margin | — | -3.1% |
| Revenue YoY | — | 6.7% |
| Net Profit YoY | — | -161.5% |
| EPS (diluted) | — | $-0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $213.7M | ||
| Q2 25 | — | $235.8M | ||
| Q1 25 | $77.5M | $249.5M | ||
| Q4 24 | — | $213.6M | ||
| Q3 24 | — | $200.2M | ||
| Q2 24 | — | $212.9M | ||
| Q1 24 | $116.1M | $227.8M | ||
| Q4 23 | — | $221.1M |
| Q3 25 | — | $-6.5M | ||
| Q2 25 | — | $9.7M | ||
| Q1 25 | — | $9.4M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $10.6M | ||
| Q2 24 | — | $10.4M | ||
| Q1 24 | — | $16.5M | ||
| Q4 23 | — | — |
| Q3 25 | — | 77.2% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | 25.3% | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% | ||
| Q2 24 | — | 81.1% | ||
| Q1 24 | 24.8% | 81.1% | ||
| Q4 23 | — | 80.9% |
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 7.1% | ||
| Q1 25 | 6.7% | 6.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | 1.9% | 10.8% | ||
| Q4 23 | — | 11.0% |
| Q3 25 | — | -3.1% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | 4.9% | ||
| Q1 24 | — | 7.3% | ||
| Q4 23 | — | — |
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.49 | ||
| Q4 24 | — | $0.23 | ||
| Q3 24 | — | $0.56 | ||
| Q2 24 | — | $0.54 | ||
| Q1 24 | — | $0.86 | ||
| Q4 23 | — | $0.87 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $145.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $528.1M |
| Total Assets | — | $726.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $145.3M | ||
| Q2 25 | — | $151.3M | ||
| Q1 25 | — | $179.6M | ||
| Q4 24 | — | $181.8M | ||
| Q3 24 | — | $364.9M | ||
| Q2 24 | — | $332.4M | ||
| Q1 24 | — | $328.3M | ||
| Q4 23 | — | $330.4M |
| Q3 25 | — | $528.1M | ||
| Q2 25 | — | $531.1M | ||
| Q1 25 | — | $529.8M | ||
| Q4 24 | — | $532.1M | ||
| Q3 24 | — | $533.1M | ||
| Q2 24 | — | $512.2M | ||
| Q1 24 | — | $500.0M | ||
| Q4 23 | — | $497.2M |
| Q3 25 | — | $726.6M | ||
| Q2 25 | — | $734.5M | ||
| Q1 25 | — | $746.6M | ||
| Q4 24 | — | $748.2M | ||
| Q3 24 | — | $671.3M | ||
| Q2 24 | — | $631.4M | ||
| Q1 24 | — | $629.3M | ||
| Q4 23 | — | $632.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-2.0M |
| Free Cash FlowOCF − Capex | — | $-5.2M |
| FCF MarginFCF / Revenue | — | -2.4% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $18.7M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-2.0M | ||
| Q2 25 | — | $12.2M | ||
| Q1 25 | — | $15.5M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | — | $29.5M | ||
| Q2 24 | — | $8.0M | ||
| Q1 24 | — | $17.7M | ||
| Q4 23 | — | $26.0M |
| Q3 25 | — | $-5.2M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $12.7M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $27.1M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $14.5M | ||
| Q4 23 | — | $18.7M |
| Q3 25 | — | -2.4% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 6.4% | ||
| Q4 23 | — | 8.5% |
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 1.4% | ||
| Q4 23 | — | 3.3% |
| Q3 25 | — | — | ||
| Q2 25 | — | 1.27× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | 2.78× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 1.07× | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SNDL
Segment breakdown not available.
USNA
| Direct Selling | $175.8M | 82% |
| Hiya | $30.8M | 14% |
| All Other | $7.0M | 3% |
